Mechanisms of Injury - When Good Drugs Go Bad
- Intrinsic (Predictable): Dose-related, direct hepatocyte damage from a toxic metabolite.
- Classic example: Acetaminophen.
- Idiosyncratic (Unpredictable): Not dose-related; variable latency.
- Immune-mediated: Allergic features like fever, rash, eosinophilia (e.g., Halothane, Phenytoin).
- Non-immune: Metabolic abnormality (e.g., Isoniazid).

⭐ Acetaminophen overdose depletes glutathione (GSH), causing accumulation of the toxic metabolite NAPQI, which leads to centrilobular necrosis.
Patterns of Injury - Hepatocellular vs. Cholestatic
- Classification is based on the pattern of liver enzyme elevation. The R-value quantifies the type of injury:
- $R = (ALT / ULN_{ALT}) / (ALP / ULN_{ALP})$
| Pattern | R-Value | Primary Labs | Key Drug Culprits |
|---|---|---|---|
| Hepatocellular | >5 | ↑↑ ALT, AST | Acetaminophen, Isoniazid, Statins, NSAIDs |
| Cholestatic | <2 | ↑↑ ALP, GGT | Anabolic steroids, OCPs, Erythromycin |
| Mixed | 2-5 | ↑ ALT & ALP | Phenytoin, Carbamazepine, Sulfonamides |
⭐ Hy's Law: A key prognostic indicator for fatal DILI. It combines hepatocellular injury (jaundice with ↑ bilirubin) and significant ↑ aminotransferase levels, without initial cholestasis (normal ALP). This pattern signals a high risk of acute liver failure with >10% mortality.
Causative Agents - The Usual Suspects
-
Predictable (Intrinsic/Dose-Dependent):
- Acetaminophen: The classic example. Overdose depletes glutathione, leading to accumulation of toxic metabolite NAPQI and centrilobular necrosis.
-
Idiosyncratic (Unpredictable/Host-Dependent):
- Hepatocellular Pattern (↑↑ ALT):
- Anti-TB drugs (Isoniazid, Rifampin, Pyrazinamide)
- Antiepileptics (Valproate, Phenytoin)
- Statins, Ketoconazole, Halothane, Allopurinol
- Cholestatic Pattern (↑↑ ALP):
- Antibiotics (Amoxicillin-clavulanate, Erythromycin)
- Hormones (Anabolic steroids, Oral contraceptives)
- Antipsychotics (Chlorpromazine)
- Mixed Pattern:
- Carbamazepine, Phenytoin, Sulfonamides
- Hepatocellular Pattern (↑↑ ALT):
⭐ Amoxicillin-clavulanate is a leading cause of idiosyncratic DILI, typically presenting as cholestatic or mixed hepatitis. The injury can have a delayed onset of weeks to months after the drug is stopped.
Diagnosis & Management - Spotting & Stopping Toxins
- History is Key: Detailed review of all medications, supplements, & herbal products (timing is crucial).
- Pattern Recognition (R-Value):
- Calculate: $R = (\text{ALT} / \text{ULN}) / (\text{ALP} / \text{ULN})$
- Hepatocellular: $R \ge \textbf{5}$
- Cholestatic: $R \le \textbf{2}$
- Mixed: $R > \textbf{2}$ and $< \textbf{5}$

- Core Management:
- Discontinue the suspected offending agent immediately.
- Primarily supportive care.
- N-acetylcysteine (NAC) for acetaminophen toxicity.
- Consider liver biopsy if diagnosis is uncertain.
⭐ Amoxicillin-clavulanate is a classic cause of DILI, often presenting with a delayed cholestatic picture weeks after drug cessation.
High‑Yield Points - ⚡ Biggest Takeaways
- Acetaminophen toxicity is the most common cause of DILI; the antidote is N-acetylcysteine.
- DILI is classified as intrinsic (predictable, dose-related) or idiosyncratic (unpredictable).
- Centrilobular (Zone 3) necrosis is characteristic of injury from toxic metabolites, like with acetaminophen.
- Reye syndrome is a pediatric DILI caused by aspirin use during a viral infection.
- Key hepatotoxic drugs include anti-tuberculosis agents, amiodarone, methotrexate, and valproic acid.
- A thorough drug history is the most critical step in diagnosing DILI.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app